Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
J Korean Surg Soc. 2013 Apr;84(4):245-251. English. Original Article. https://doi.org/10.4174/jkss.2013.84.4.245
Kim YK , Kim SH , Moon IS , Han SS , Cho SY , You T , Park SJ .
Center for Liver Cancer, National Cancer Center, Goyang, Korea. kshlj@hanmail.net
Department of Surgery, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea. ismoon@catholic.ac.kr
Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Abstract

PURPOSE: There is controversy concerning the effect of a positive T-lymphocytotoxic crossmatch (TLC) on clinical outcomes in adult living donor liver transplantation (LDLT). The aim of this study was to investigate the effect of TLC on clinical outcomes in LDLT and to determine how long a pretransplant positive TLC continues after liver transplantation (LT). METHODS: Between January 2005 and June 2010, 219 patients underwent adult LDLT at National Cancer Center. The TLC test was routinely performed before LDLT. TLC test results were positive in 8 patients (3.7%). Patients were divided into 2 groups according to the result of TLC: positive TLC (n = 8) and negative TLC (n = 211) groups. All patients with a pretransplant positive TLC (n = 6) underwent a TLC test every week until negative conversion of TLC, except 2 patients who refused to receive the TLC test. RESULTS: Acute cellular rejection, surgical complications and patient or graft survival were not significantly different between both groups. All patients with a positive TLC (n = 6) had a posttransplant negative TLC. The median time to negative conversion of TLC was 1.5 weeks (range, 1 to 3 weeks). CONCLUSION: A pretransplant positive TLC does not affect clinical outcomes in adult LDLT. Moreover, T-lymphocytotoxic cross-reactivity disappeared within 3 weeks (range, 1 to 3 weeks) after LT.

Copyright © 2019. Korean Association of Medical Journal Editors.